21Nov 2022
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modeling of type 2 diabetes

The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modeling of type 2 diabetes

The cardiovascular safety of these interventions has been assessed individually versus placebo in multiple cardiovascular outcomes trials (CVOTs), statistically powered to detect differences in a composite endpoint of major adverse cardiovascular events (MACE). The primary concerns are around the heterogeneity of the trials, with different study durations, inclusion criteria, rescue medication protocols and endpoint definitions – this results in significant uncertainty when comparing two or more interventions evaluated in separate CVOTs, as robust adjustment for these differences is difficult. Ideally, model development should utilize patient‐level data from CVOTs to prepare novel risk equations that can better model modern therapies for type 2 diabetes.

  • #endo-diabetology

Like

Save

Share